Linical Co., Ltd. (TYO:2183)
Japan · Delayed Price · Currency is JPY 317.00
+3.00 (0.96%)
At close: Feb 6, 2026
Linical Revenue
Linical had revenue of 2.23B JPY in the quarter ending September 30, 2025, a decrease of -10.69%. This brings the company's revenue in the last twelve months to 9.87B, down -15.42% year-over-year. In the fiscal year ending March 31, 2025, Linical had annual revenue of 10.44B, down -15.19%.
Revenue (ttm)
9.87B
Revenue Growth
-15.42%
P/S Ratio
0.72
Revenue / Employee
16.51M
Employees
598
Market Cap
7.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.44B | -1.87B | -15.19% |
| Mar 31, 2024 | 12.31B | -209.00M | -1.67% |
| Mar 31, 2023 | 12.52B | 961.00M | 8.32% |
| Mar 31, 2022 | 11.56B | 1.28B | 12.41% |
| Mar 31, 2021 | 10.28B | -656.00M | -6.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kohjin Bio | 5.20B |
| Soiken Holdings | 4.87B |
| CellSource | 3.71B |
| MEDINET | 998.00M |
| OncoTherapy Science | 956.00M |
| Chiome Bioscience | 727.99M |
| PRISM BioLab Co.,LTD | 677.33M |
| ADR120S | 49.00M |